Skip to content
Join us
Events
International work
Login
Membership
Who we are
How to join the College
Member benefits
Existing members
Medical examiners
Corporate membership
Member engagement
Subscription fees 2026
Get involved at the College: volunteer roles
Services and resources
CPD, appraisal and revalidation
Learning Environment for Pathology Trainees (LEPT) system
Guidelines and publications
Webinars
Pathology Portal
Events
Workforce and engagement
Patient safety and quality improvement
Exams and training
Examinations
Training
Curricula
Specialist registration
Discover pathology
Specialties
What is pathology?
Careers in pathology
Undergraduates and foundation doctors
About the College
News and advocacy
Strategies and policies
Awards and bursaries
Governance and committees
Research and innovation
RCPath Consulting
College vacancies
Document library
Join us
Events
International work
Login
You are here:
Homepage
Document library
Homologous Recombination Deficiency (HRD) testing in advanced high grade ovarian cancer – An audit
26 Oct 2022
by Kallpana Dhas
Homologous Recombination Deficiency (HRD) testing in advanced high grade ovarian cancer – An audit
Homologous Recombination Deficiency (HRD) testing in advanced high grade ovarian cancer – An audit
258 KB
Download
Return to listing
